Logo image of CBK.DE

COMMERZBANK AG (CBK.DE) Stock Fundamental Analysis

FRA:CBK - Deutsche Boerse Ag - DE000CBK1001 - Common Stock - Currency: EUR

28.29  +0.56 (+2.02%)

Fundamental Rating

2

Taking everything into account, CBK scores 2 out of 10 in our fundamental rating. CBK was compared to 96 industry peers in the Banks industry. CBK may be in some trouble as it scores bad on both profitability and health. CBK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CBK was profitable.
CBK had a negative operating cash flow in the past year.
CBK had positive earnings in 4 of the past 5 years.
In multiple years CBK reported negative operating cash flow during the last 5 years.
CBK.DE Yearly Net Income VS EBIT VS OCF VS FCFCBK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B

1.2 Ratios

CBK has a worse Return On Assets (0.44%) than 71.88% of its industry peers.
The Return On Equity of CBK (7.15%) is worse than 65.63% of its industry peers.
Industry RankSector Rank
ROA 0.44%
ROE 7.15%
ROIC N/A
ROA(3y)0.37%
ROA(5y)0.12%
ROE(3y)5.88%
ROE(5y)1.6%
ROIC(3y)N/A
ROIC(5y)N/A
CBK.DE Yearly ROA, ROE, ROICCBK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

CBK has a Profit Margin (19.01%) which is in line with its industry peers.
CBK's Profit Margin has improved in the last couple of years.
CBK does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 19.01%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y87.93%
PM growth 5Y25.01%
GM growth 3YN/A
GM growth 5YN/A
CBK.DE Yearly Profit, Operating, Gross MarginsCBK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

CBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CBK has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CBK has been reduced compared to 5 years ago.
The debt/assets ratio for CBK is higher compared to a year ago.
CBK.DE Yearly Shares OutstandingCBK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CBK.DE Yearly Total Debt VS Total AssetsCBK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B 500B

2.2 Solvency

A Debt/Equity ratio of 1.59 is on the high side and indicates that CBK has dependencies on debt financing.
CBK has a better Debt to Equity ratio (1.59) than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC13.49%
CBK.DE Yearly LT Debt VS Equity VS FCFCBK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBK.DE Yearly Current Assets VS Current LiabilitesCBK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

CBK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.96%, which is quite good.
The Earnings Per Share has been growing by 28.05% on average over the past years. This is a very strong growth
CBK shows a small growth in Revenue. In the last year, the Revenue has grown by 3.72%.
The Revenue has been growing slightly by 6.65% on average over the past years.
EPS 1Y (TTM)15.96%
EPS 3Y103.28%
EPS 5Y28.05%
EPS Q2Q%25.81%
Revenue 1Y (TTM)3.72%
Revenue growth 3Y8.47%
Revenue growth 5Y6.65%
Sales Q2Q%7.35%

3.2 Future

CBK is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.63% yearly.
CBK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.89% yearly.
EPS Next Y6.3%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
EPS Next 5Y7.63%
Revenue Next Year8.03%
Revenue Next 2Y7.51%
Revenue Next 3Y6.94%
Revenue Next 5Y3.89%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CBK.DE Yearly Revenue VS EstimatesCBK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CBK.DE Yearly EPS VS EstimatesCBK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.52, which indicates a correct valuation of CBK.
Based on the Price/Earnings ratio, CBK is valued a bit more expensive than the industry average as 76.04% of the companies are valued more cheaply.
CBK is valuated cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.72, the valuation of CBK can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBK is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CBK to the average of the S&P500 Index (22.19), we can say CBK is valued rather cheaply.
Industry RankSector Rank
PE 12.52
Fwd PE 9.72
CBK.DE Price Earnings VS Forward Price EarningsCBK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBK.DE Per share dataCBK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CBK's earnings are expected to grow with 18.63% in the coming years.
PEG (NY)1.99
PEG (5Y)0.45
EPS Next 2Y17.71%
EPS Next 3Y18.63%

More info and screens

4

5. Dividend

5.1 Amount

CBK has a Yearly Dividend Yield of 2.32%.
Compared to an average industry Dividend Yield of 5.14, CBK's dividend is way lower than its industry peers. On top of this 90.63% of the companies listed in the same industry pay a better dividend than CBK!
CBK's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

On average, the dividend of CBK grows each year by 11.38%, which is quite nice.
Dividend Growth(5Y)11.38%
Div Incr Years1
Div Non Decr Years2
CBK.DE Yearly Dividends per shareCBK.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

CBK pays out 16.84% of its income as dividend. This is a sustainable payout ratio.
CBK's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP16.84%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
CBK.DE Yearly Income VS Free CF VS DividendCBK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B
CBK.DE Dividend Payout.CBK.DE Dividend Payout, showing the Payout Ratio.CBK.DE Dividend Payout.PayoutRetained Earnings

More info and screens

COMMERZBANK AG

FRA:CBK (6/20/2025, 5:36:15 PM)

28.29

+0.56 (+2.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners41.92%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap33.51B
Analysts78.18
Price Target27.32 (-3.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly Dividend0.34
Dividend Growth(5Y)11.38%
DP16.84%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.62%
Min EPS beat(2)32.01%
Max EPS beat(2)83.22%
EPS beat(4)3
Avg EPS beat(4)22.65%
Min EPS beat(4)-35.08%
Max EPS beat(4)83.22%
EPS beat(8)6
Avg EPS beat(8)19.12%
EPS beat(12)8
Avg EPS beat(12)16.16%
EPS beat(16)11
Avg EPS beat(16)55.67%
Revenue beat(2)2
Avg Revenue beat(2)1.84%
Min Revenue beat(2)1.03%
Max Revenue beat(2)2.64%
Revenue beat(4)3
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-1.15%
Max Revenue beat(4)2.64%
Revenue beat(8)6
Avg Revenue beat(8)23.86%
Revenue beat(12)10
Avg Revenue beat(12)25.44%
Revenue beat(16)14
Avg Revenue beat(16)22.89%
PT rev (1m)11.7%
PT rev (3m)28.03%
EPS NQ rev (1m)3.59%
EPS NQ rev (3m)-2.99%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.56%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.85%
Valuation
Industry RankSector Rank
PE 12.52
Fwd PE 9.72
P/S 2.58
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)2.26
EY7.99%
EPS(NY)2.91
Fwd EY10.29%
FCF(TTM)-18.12
FCFYN/A
OCF(TTM)-17.15
OCFYN/A
SpS10.94
BVpS29.09
TBVpS27.59
PEG (NY)1.99
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 7.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 19.01%
GM N/A
FCFM N/A
ROA(3y)0.37%
ROA(5y)0.12%
ROE(3y)5.88%
ROE(5y)1.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y87.93%
PM growth 5Y25.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.16%
Cap/Sales 8.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC13.49%
ROIC/WACCN/A
Cap/Depr(3y)98.87%
Cap/Depr(5y)65.9%
Cap/Sales(3y)7.2%
Cap/Sales(5y)8.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.96%
EPS 3Y103.28%
EPS 5Y28.05%
EPS Q2Q%25.81%
EPS Next Y6.3%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
EPS Next 5Y7.63%
Revenue 1Y (TTM)3.72%
Revenue growth 3Y8.47%
Revenue growth 5Y6.65%
Sales Q2Q%7.35%
Revenue Next Year8.03%
Revenue Next 2Y7.51%
Revenue Next 3Y6.94%
Revenue Next 5Y3.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-211.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.16%
OCF growth 3YN/A
OCF growth 5YN/A